Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Endo International

Endo International reported $606.64M in Current Liabilities for its fiscal quarter ending in March of 2023.

Current Liabilities Change
Amarin AMRN:US USD 244.24M 15.24M
ANI Pharmaceuticals ANIP:US USD 125.82M 26.39M
Coherus Biosciences CHRS:US USD 123.41M 15.29M
Eli Lilly LLY:US USD 16.01B 1.13B
Endo International ENDP:US USD 606.64M 82.98M
Heron Therapeutics HRTX:US USD 77.9M 4.46M
Hikma Pharmaceutical HIK:LN USD 1.08B 67M
Horizon Pharma HZNP:US USD 884.89M 64.25M
Ligand Pharmaceuticals LGND:US USD 98.93M 119K
Novartis NOVN:VX USD 30.55B 1.89B
Pacira PCRX:US USD 98.7M 49.08M
Patterson Companies PDCO:US USD 1.17B 29.88M
Perrigo PRGO:US USD 1.09B 26.8M
Phibro Animal Health PAHC:US USD 165.31M 2.26M
Revance Therapeutics RVNC:US USD 77.98M 2.3M
Supernus Pharmaceuticals SUPN:US USD 731.54M 43.59M
Takeda 4502:JP JPY 2.48T 245.13B
Teva Pharmaceutical Industries Ltd TEVA:IT USD 10.41B 1.06B
Xeris Pharmaceuticals Inc XERS:US USD 81.42M 7.8M
Zoetis ZTS:US USD 1.92B 1.25B